US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Maison Solutions

0.2532

+0.00672.72%

Post-market: 0.2470-0.0062-2.45%19:25 EST

Volume:131.67K

Turnover:33.78K

Market Cap:6.39M

PE:-0.94

High:0.2749

Open:0.2430

Low:0.2413

Close:0.2465

52wk High:3.96

52wk Low:0.2413

Shares:25.23M

Float Shares:8.63M

Volume Ratio:0.39

T/O Rate:1.53%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2700

EPS(LYR):0.0670

ROE:-54.47%

ROA:-4.29%

PB:0.55

PE(LYR):3.78

Loading ...

Overview Company News Filings

SK shieldus Recognized by IDC as a Major Player for MDR in Asia-Pacific

Maison Solutions exits Arcadia joint venture stake

Maison Solutions Inc. Sells 49% Stake in HKGF Market of Arcadia for $1

Oncolytics Biotech® Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

Expanding Nadunolimab’s Oncology Footprint: Low-Cost MSS-CRC Study De-Risks Pivotal Pancreatic Program and Supports Buy Rating on Cantargia AB

Press Release: Adagene Provides Business Update and 2026 Objectives

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11

Maison Solutions Is Maintained at Buy by Ascendiant Capital

Maison Solutions Q2 EPS $(0.23) Down From $(0.01) YoY, Sales $27.625M Miss $29.500M Estimate

BRIEF-Maison Solutions Inc Enters Consent And Waiver With Investor

Maison Solutions Inc - Enters Consent and Waiver With Investor - SEC Filing

THOMSON REUTERS

Maison Solutions: Under Agreement, Some Restrictive Covenants in Notes & Their Related Transaction Documents Were Waived for a Limited Purpose

THOMSON REUTERS

Maison Solutions Inc. Delays Financial Report Filing

Consumer Tech News (Dec 1-5): Trump Says He's Back in Elon Musk's Social Circle, U.S. Suspends China MSS Sanctions & More

Benzinga_recent_news

US Reportedly Pauses Salt-Typhoon Sanctions On China, Shelves New Export Controls To Protect Trade Truce

Benzinga_recent_news

MIIT Launches Commercial Trials for Satellite IoT Services

China threat policy questioned amid urgent MI5 warnings

MI5 warned Whitehall China uses LinkedIn to spy on MPs

Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results

Press Release: Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MSS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSS\",,,,,undefined,":{"symbol":"MSS","market":"US","secType":"STK","nameCN":"Maison Solutions","latestPrice":0.2532,"timestamp":1770411600000,"preClose":0.2465,"halted":0,"volume":131669,"hourTrading":{"tag":"盘后","latestPrice":0.247,"preClose":0.2532,"latestTime":"19:25 EST","volume":9873,"amount":2468.6152,"timestamp":1770423904016,"change":-0.0062,"changeRate":-0.024487,"amplitude":0.107425},"delay":0,"changeRate":0.027180527383367074,"floatShares":8629700,"shares":25229699,"eps":-0.27,"marketStatus":"Market Closed","change":0.0067,"latestTime":"02-06 16:00:00 EST","open":0.243,"high":0.2749,"low":0.2413,"amount":33779.2474423,"amplitude":0.136308,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.27,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1686801600000,"exchange":"NASDAQ","adjPreClose":0.2465,"preHourTrading":{"tag":"盘前","latestPrice":0.2527,"preClose":0.2465,"latestTime":"08:00 EST","volume":4000,"amount":1008.19992,"timestamp":1770382805522,"change":0.0062,"changeRate":0.025152,"amplitude":0.005274},"postHourTrading":{"tag":"盘后","latestPrice":0.247,"preClose":0.2532,"latestTime":"19:25 EST","volume":9873,"amount":2468.6152,"timestamp":1770423904016,"change":-0.0062,"changeRate":-0.024487,"amplitude":0.107425},"volumeRatio":0.39394492457788477},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSS\",,,,,undefined,":{"symbol":"MSS","floatShares":8629700,"roa":"-4.29%","roe":"-54.47%","lyrEps":0.067005,"volumeRatio":0.39394492457788477,"shares":25229699,"dividePrice":0,"high":0.2749,"amplitude":0.136308,"preClose":0.2465,"low":0.2413,"week52Low":0.2413,"pbRate":"0.55","psRate":"0.05","week52High":3.9599,"institutionHeld":0,"latestPrice":0.2532,"eps":-0.27,"divideRate":0,"volume":131669,"delay":0,"ttmEps":-0.27,"open":0.243,"prevYearClose":0.3176,"prevWeekClose":0.2559,"prevMonthClose":0.2559,"prevQuarterClose":0.3176,"fiveDayClose":0.2559,"twentyDayClose":0.3395,"sixtyDayClose":0.5197},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-22","symbol":"MSS","fiscalQuarterEnding":"2025/10","expectedEps":0,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1766379600000,"reportTimeType":"post","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MSS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1767157200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MSS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MSS","date":"2026-02-06","current":-0.937778,"percent":0.757951,"low":-131.978833,"twenty":-15.863874,"median":-8.745756,"eighty":14.024294,"high":171.736597,"avg":-9.719623,"sd":52.567042,"marketCap":6219109},"quantilePoints":[{"date":"2023-10-06","current":95.051104,"twenty":42.433528,"median":42.433528,"eighty":52.957043,"marketCap":165760000},{"date":"2023-10-13","current":53.890581,"twenty":42.433528,"median":52.19324,"eighty":70.694259,"marketCap":93980000},{"date":"2023-10-20","current":85.821811,"twenty":42.433528,"median":55.481838,"eighty":70.694259,"marketCap":149665000},{"date":"2023-10-27","current":82.74538,"twenty":44.046002,"median":56.330509,"eighty":81.726975,"marketCap":144300000},{"date":"2023-11-03","current":84.12447,"twenty":51.089968,"median":63.915503,"eighty":85.482343,"marketCap":146705000},{"date":"2023-11-10","current":96.960613,"twenty":53.551113,"median":69.378819,"eighty":87.328201,"marketCap":169090000},{"date":"2023-11-17","current":98.817079,"twenty":54.208832,"median":80.199368,"eighty":94.520685,"marketCap":172327500},{"date":"2023-11-24","current":140.573349,"twenty":55.481838,"median":84.97314,"eighty":96.960613,"marketCap":245146426},{"date":"2023-12-01","current":163.945785,"twenty":56.330509,"median":86.140063,"eighty":104.492564,"marketCap":285905711},{"date":"2023-12-08","current":163.719965,"twenty":58.240018,"median":88.420865,"eighty":140.573349,"marketCap":285511902},{"date":"2023-12-15","current":171.736597,"twenty":59.40694,"median":91.656421,"eighty":155.816242,"marketCap":299492139},{"date":"2023-12-22","current":25.627315,"twenty":53.890581,"median":88.420865,"eighty":152.316023,"marketCap":33473809},{"date":"2023-12-29","current":20.803349,"twenty":47.270951,"median":87.625236,"eighty":147.980266,"marketCap":27172856},{"date":"2024-01-05","current":17.336124,"twenty":42.433528,"median":86.087021,"eighty":144.841359,"marketCap":22644047},{"date":"2024-01-12","current":13.568909,"twenty":34.099403,"median":84.12447,"eighty":143.192868,"marketCap":17723397},{"date":"2024-01-19","current":11.411692,"twenty":24.572072,"median":77.653357,"eighty":140.573349,"marketCap":14905690},{"date":"2024-01-26","current":12.831747,"twenty":17.788371,"median":69.166652,"eighty":140.573349,"marketCap":16760533},{"date":"2024-02-02","current":13.733225,"twenty":15.074891,"median":59.40694,"eighty":106.508156,"marketCap":17938023},{"date":"2024-02-09","current":16.58238,"twenty":14.125173,"median":55.906174,"eighty":105.447318,"marketCap":21659523},{"date":"2024-02-16","current":25.175067,"twenty":14.548777,"median":53.466246,"eighty":104.492564,"marketCap":32883094},{"date":"2024-02-23","current":21.104847,"twenty":14.726058,"median":42.433528,"eighty":104.32283,"marketCap":27566666},{"date":"2024-03-01","current":23.064583,"twenty":15.013988,"median":42.433528,"eighty":102.667922,"marketCap":30126428},{"date":"2024-03-08","current":23.818328,"twenty":15.316089,"median":36.028989,"eighty":99.506624,"marketCap":31110952},{"date":"2024-03-15","current":19.29586,"twenty":16.341182,"median":28.039296,"eighty":97.331906,"marketCap":25203809},{"date":"2024-03-22","current":-113.246356,"twenty":14.726058,"median":26.833306,"eighty":95.433006,"marketCap":26188333},{"date":"2024-03-28","current":-118.355211,"twenty":13.992212,"median":25.627315,"eighty":93.459846,"marketCap":27369761},{"date":"2024-04-05","current":-107.286018,"twenty":13.539061,"median":24.948944,"eighty":91.953456,"marketCap":24809999},{"date":"2024-04-12","current":-102.177162,"twenty":13.066915,"median":24.270574,"eighty":90.128814,"marketCap":23628571},{"date":"2024-04-19","current":-103.880113,"twenty":11.529276,"median":23.969076,"eighty":89.04676,"marketCap":24022380},{"date":"2024-04-26","current":-93.662397,"twenty":-30.862157,"median":23.667579,"eighty":88.304173,"marketCap":21659523},{"date":"2024-05-03","current":-88.553541,"twenty":-92.12974,"median":23.064583,"eighty":87.710103,"marketCap":20478095},{"date":"2024-05-10","current":-102.177162,"twenty":-99.62273,"median":22.913834,"eighty":86.734132,"marketCap":23628571},{"date":"2024-05-17","current":-103.028636,"twenty":-100.474208,"median":21.858591,"eighty":86.076413,"marketCap":23825475},{"date":"2024-05-24","current":-91.959447,"twenty":-100.474208,"median":20.803349,"eighty":85.906678,"marketCap":21265714},{"date":"2024-05-31","current":-92.81092,"twenty":-100.474208,"median":19.29586,"eighty":85.142875,"marketCap":21462618},{"date":"2024-06-07","current":-97.068302,"twenty":-100.474208,"median":18.391367,"eighty":83.572834,"marketCap":22447142},{"date":"2024-06-14","current":-120.909639,"twenty":-100.474208,"median":17.562248,"eighty":81.726975,"marketCap":27960475},{"date":"2024-06-21","current":-108.137496,"twenty":-102.177162,"median":16.808503,"eighty":77.653357,"marketCap":25006904},{"date":"2024-06-28","current":-123.464072,"twenty":-102.177162,"median":15.979384,"eighty":77.483623,"marketCap":28551190},{"date":"2024-07-05","current":-112.394878,"twenty":-102.177162,"median":14.922634,"eighty":75.658981,"marketCap":25991428},{"date":"2024-07-12","current":-108.988973,"twenty":-103.709818,"median":14.125173,"eighty":69.293952,"marketCap":25203809},{"date":"2024-07-15","current":-110.691923,"twenty":-104.385891,"median":14.100299,"eighty":69.209085,"marketCap":25597618},{"date":"2024-08-02","current":-90.256492,"twenty":-104.217298,"median":14.075425,"eighty":69.124218,"marketCap":20871904},{"date":"2024-08-09","current":-77.484348,"twenty":-103.369227,"median":13.651067,"eighty":68.636233,"marketCap":17918333},{"date":"2024-08-16","current":-5.24654,"twenty":-103.028636,"median":13.49655,"eighty":63.01379,"marketCap":17524523},{"date":"2024-08-23","current":-3.995564,"twenty":-102.773194,"median":13.146812,"eighty":58.706787,"marketCap":13346007},{"date":"2024-08-30","current":-4.22317,"twenty":-102.347457,"median":12.831747,"eighty":57.094313,"marketCap":14106257},{"date":"2024-09-06","current":-4.83448,"twenty":-102.177162,"median":11.607666,"eighty":55.991041,"marketCap":16148159},{"date":"2024-09-13","current":-4.347554,"twenty":-102.177162,"median":11.115471,"eighty":54.845335,"marketCap":14521726},{"date":"2024-09-20","current":-4.715991,"twenty":-102.177162,"median":-3.808162,"eighty":53.720847,"marketCap":15752380},{"date":"2024-09-27","current":-10.100234,"twenty":-102.177162,"median":-3.90838,"eighty":52.278107,"marketCap":25597618},{"date":"2024-10-04","current":-9.478681,"twenty":-102.177162,"median":-3.985012,"eighty":47.270951,"marketCap":24022380},{"date":"2024-10-11","current":-9.711763,"twenty":-101.836571,"median":-4.110575,"eighty":42.433528,"marketCap":24613095},{"date":"2024-10-18","current":-8.235575,"twenty":-101.325685,"median":-4.244392,"eighty":42.433528,"marketCap":20871904},{"date":"2024-10-25","current":-7.847105,"twenty":-100.985094,"median":-4.358165,"eighty":42.433528,"marketCap":19887380},{"date":"2024-10-31","current":-7.110564,"twenty":-100.474208,"median":-4.421241,"eighty":41.484268,"marketCap":18020723},{"date":"2024-11-08","current":-8.157881,"twenty":-100.474208,"median":-4.598091,"eighty":37.35558,"marketCap":20674999},{"date":"2024-11-15","current":-7.614022,"twenty":-100.474208,"median":-4.763445,"eighty":35.546593,"marketCap":19296666},{"date":"2024-11-22","current":-7.610915,"twenty":-100.474208,"median":-4.848628,"eighty":32.682364,"marketCap":19288790},{"date":"2024-11-29","current":-7.304023,"twenty":-100.474208,"median":-5.421621,"eighty":28.94379,"marketCap":18511016},{"date":"2024-12-06","current":-6.992469,"twenty":-99.62273,"median":-5.705759,"eighty":27.134803,"marketCap":17721428},{"date":"2024-12-13","current":-8.080187,"twenty":-99.62273,"median":-6.992469,"eighty":27.134803,"marketCap":20478095},{"date":"2024-12-20","current":-7.310906,"twenty":-99.62273,"median":-7.07094,"eighty":26.833306,"marketCap":21068809},{"date":"2024-12-27","current":-7.925842,"twenty":-98.26037,"median":-7.186705,"eighty":25.868513,"marketCap":22840952},{"date":"2025-01-03","current":-8.472451,"twenty":-97.408893,"median":-7.304023,"eighty":25.627315,"marketCap":24416190},{"date":"2025-01-10","current":-8.814083,"twenty":-97.068302,"median":-7.345923,"eighty":25.446416,"marketCap":25400714},{"date":"2025-01-17","current":-7.242579,"twenty":-97.068302,"median":-7.379232,"eighty":25.114768,"marketCap":20871904},{"date":"2025-01-24","current":-7.720863,"twenty":-96.727712,"median":-7.38094,"eighty":24.994169,"marketCap":22250237},{"date":"2025-01-31","current":-7.648437,"twenty":-95.195057,"median":-7.420176,"eighty":24.81327,"marketCap":22041518},{"date":"2025-02-07","current":-7.857515,"twenty":-94.513875,"median":-7.443095,"eighty":24.511772,"marketCap":22644047},{"date":"2025-02-14","current":-8.609104,"twenty":-94.343579,"median":-7.452707,"eighty":24.240424,"marketCap":24809999},{"date":"2025-02-21","current":-8.745756,"twenty":-93.662397,"median":-7.458634,"eighty":24.119825,"marketCap":25203809},{"date":"2025-02-28","current":-8.13082,"twenty":-93.662397,"median":-7.515884,"eighty":24.119825,"marketCap":23431666},{"date":"2025-03-07","current":-9.292366,"twenty":-92.81092,"median":-7.526106,"eighty":23.818328,"marketCap":26779047},{"date":"2025-03-14","current":-9.22404,"twenty":-92.81092,"median":-7.54099,"eighty":23.818328,"marketCap":26582142},{"date":"2025-03-21","current":-15.798691,"twenty":-91.959447,"median":-7.58421,"eighty":23.667579,"marketCap":20871904},{"date":"2025-03-28","current":-16.842001,"twenty":-91.959447,"median":-7.614022,"eighty":23.51683,"marketCap":22250237},{"date":"2025-04-04","current":-15.351559,"twenty":-91.107969,"median":-7.646769,"eighty":23.064583,"marketCap":20281190},{"date":"2025-04-11","current":-15.351559,"twenty":-91.107969,"median":-7.652869,"eighty":23.064583,"marketCap":20281190},{"date":"2025-04-17","current":-15.05347,"twenty":-90.433599,"median":-7.691717,"eighty":23.064583,"marketCap":19887380},{"date":"2025-04-25","current":-14.475179,"twenty":-90.258195,"median":-7.745137,"eighty":22.943984,"marketCap":19123390},{"date":"2025-05-02","current":-14.680859,"twenty":-89.57531,"median":-7.847105,"eighty":22.431437,"marketCap":19395118},{"date":"2025-05-09","current":-13.042863,"twenty":-88.723836,"median":-7.847105,"eighty":22.190239,"marketCap":17231135},{"date":"2025-05-16","current":-14.345495,"twenty":-88.553541,"median":-7.857515,"eighty":21.677693,"marketCap":18952063},{"date":"2025-05-23","current":-15.05347,"twenty":-85.828817,"median":-7.924799,"eighty":21.195296,"marketCap":19887380},{"date":"2025-05-30","current":-13.123347,"twenty":-83.104091,"median":-7.925842,"eighty":20.923948,"marketCap":17337464},{"date":"2025-06-06","current":-13.266429,"twenty":-80.873221,"median":-8.062494,"eighty":20.803349,"marketCap":17526492},{"date":"2025-06-13","current":-13.23513,"twenty":-78.608296,"median":-8.105504,"eighty":19.898856,"marketCap":17485142},{"date":"2025-06-20","current":-13.424834,"twenty":-77.484348,"median":-8.13082,"eighty":19.23556,"marketCap":17735763},{"date":"2025-06-27","current":-13.041373,"twenty":-77.198252,"median":-8.164983,"eighty":18.903913,"marketCap":17229166},{"date":"2025-07-03","current":-13.442302,"twenty":-76.75889,"median":-8.199147,"eighty":18.481816,"marketCap":17758840},{"date":"2025-07-11","current":-13.413983,"twenty":-76.700987,"median":-8.267472,"eighty":18.150168,"marketCap":17721428},{"date":"2025-07-18","current":-15.05347,"twenty":-64.674697,"median":-8.335799,"eighty":17.697922,"marketCap":19887380},{"date":"2025-07-25","current":-13.649473,"twenty":-16.842001,"median":-8.404125,"eighty":17.275824,"marketCap":18032537},{"date":"2025-08-01","current":-13.002621,"twenty":-16.782383,"median":-8.540778,"eighty":16.944177,"marketCap":17177971},{"date":"2025-08-08","current":-12.670252,"twenty":-16.514104,"median":-8.577728,"eighty":16.341182,"marketCap":16738873},{"date":"2025-08-15","current":14.34762,"twenty":-16.394868,"median":-8.67743,"eighty":15.316089,"marketCap":16776285},{"date":"2025-08-22","current":13.603295,"twenty":-16.33525,"median":-8.546352,"eighty":15.013988,"marketCap":15905966},{"date":"2025-08-29","current":15.034689,"twenty":-16.09678,"median":-8.472451,"eighty":14.981827,"marketCap":17579656},{"date":"2025-09-05","current":15.82785,"twenty":-16.09678,"median":-8.404125,"eighty":15.324337,"marketCap":18507078},{"date":"2025-09-12","current":18.692322,"twenty":-15.947736,"median":-8.335799,"eighty":15.82785,"marketCap":21856428},{"date":"2025-09-19","current":16.503131,"twenty":-15.798691,"median":-8.267472,"eighty":16.503131,"marketCap":19296666},{"date":"2025-09-26","current":-17.61407,"twenty":-16.09678,"median":-8.301635,"eighty":16.307788,"marketCap":18902856},{"date":"2025-10-03","current":-19.448869,"twenty":-16.842001,"median":-8.335799,"eighty":16.034982,"marketCap":20871904},{"date":"2025-10-10","current":-17.368911,"twenty":-17.52233,"median":-8.438288,"eighty":15.89521,"marketCap":18639760},{"date":"2025-10-17","current":-15.025619,"twenty":-17.52233,"median":-8.546352,"eighty":15.82785,"marketCap":16125013},{"date":"2025-10-24","current":-15.133166,"twenty":-17.368911,"median":-8.643267,"eighty":15.627455,"marketCap":16240429},{"date":"2025-10-31","current":-14.38447,"twenty":-17.251023,"median":-8.70174,"eighty":15.376388,"marketCap":15436953},{"date":"2025-11-07","current":-12.556428,"twenty":-16.842001,"median":-8.745756,"eighty":15.329388,"marketCap":13475157},{"date":"2025-11-14","current":-12.100343,"twenty":-16.842001,"median":-8.814083,"eighty":15.324337,"marketCap":12985701},{"date":"2025-11-21","current":-9.467278,"twenty":-16.705013,"median":-8.947463,"eighty":15.074891,"marketCap":10159980},{"date":"2025-11-28","current":-10.123194,"twenty":-16.618975,"median":-8.947463,"eighty":15.042729,"marketCap":10863888},{"date":"2025-12-05","current":-12.274314,"twenty":-16.554624,"median":-9.09021,"eighty":14.996968,"marketCap":13172401},{"date":"2025-12-12","current":-10.95543,"twenty":-16.424677,"median":-9.22404,"eighty":14.895928,"marketCap":11757017},{"date":"2025-12-19","current":-10.520505,"twenty":-16.394868,"median":-9.323293,"eighty":14.790908,"marketCap":11290269},{"date":"2025-12-26","current":-1.622401,"twenty":-16.296782,"median":-9.323293,"eighty":14.637417,"marketCap":9385430},{"date":"2026-01-02","current":-1.385147,"twenty":-16.191681,"median":-9.22404,"eighty":14.477071,"marketCap":8012937},{"date":"2026-01-09","current":-1.480659,"twenty":-16.117982,"median":-9.10588,"eighty":14.360756,"marketCap":8565466},{"date":"2026-01-16","current":-1.339789,"twenty":-16.09678,"median":-9.012516,"eighty":14.258641,"marketCap":7750549},{"date":"2026-01-23","current":-1.226396,"twenty":-16.066971,"median":-8.844277,"eighty":14.115223,"marketCap":7094578},{"date":"2026-01-30","current":-1.203717,"twenty":-15.932443,"median":-8.803319,"eighty":14.065872,"marketCap":6963383},{"date":"2026-02-06","current":-1.075059,"twenty":-15.863874,"median":-8.745756,"eighty":14.024294,"marketCap":6219109}],"updateTime":1770494781932},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609314846","title":"SK shieldus Recognized by IDC as a Major Player for MDR in Asia-Pacific","url":"https://stock-news.laohu8.com/highlight/detail?id=2609314846","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609314846?lang=en_us&edition=fundamental","pubTime":"2026-02-05 07:00","pubTimestamp":1770246000,"startTime":"0","endTime":"0","summary":"SEOUL, South Korea, Feb. 5, 2026 /PRNewswire/ -- SK shieldus, a leading cybersecurity service provider, announced today that the company has been named a Major Player in theIDC MarketScape: Asia Pacific  Managed Detection and Response Services 2025 Vendor Assessment .According to the IDC MarketScape report, \"Clients value SK shieldus for its responsive monitoring, structured processes, and deep domain expertise in managing both domestic and international threat environments. The company is appreciated for maintaining continuous, uninterrupted security operations with timely incident handling and clear methodologies. Customers highlight the effectiveness of forensic analysis, threat identification, and remediation planning; and recognize the provider's role in improving detection quality and preventing incidents over multiyear engagements.\". We believe this recognition underscores SK shieldus's transformation into a global-standard MDR provider, capable of competing with leading cyberse","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/sk-shieldus-recognized-by-idc-as-a-major-player-for-mdr-in-asia-pacific-302678609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4113","BK4554","A27.SI","Y3D.SI","MTTR","MSS","BK6057"],"gpt_icon":0},{"id":"2609970433","title":"Maison Solutions exits Arcadia joint venture stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2609970433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609970433?lang=en_us&edition=fundamental","pubTime":"2026-02-05 03:47","pubTimestamp":1770234449,"startTime":"0","endTime":"0","summary":"An announcement from Maison Solutions Inc. Class A ( ($MSS) ) is now available. On January 31, 2026, Maison Solutions Inc. entered into and simulta...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maison-solutions-exits-arcadia-joint-venture-stake?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maison-solutions-exits-arcadia-joint-venture-stake?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4113","MSS"],"gpt_icon":0},{"id":"2609397309","title":"Maison Solutions Inc. Sells 49% Stake in HKGF Market of Arcadia for $1","url":"https://stock-news.laohu8.com/highlight/detail?id=2609397309","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609397309?lang=en_us&edition=fundamental","pubTime":"2026-02-05 03:18","pubTimestamp":1770232737,"startTime":"0","endTime":"0","summary":"Maison Solutions Inc. has entered into a Buy-Sell Agreement to sell its 49% ownership interest in HKGF Market of Arcadia, LLC to JC Business Guys, Inc. for $1.00. The transaction will transfer the interest free of any encumbrances, subject to the terms and conditions of the agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maison Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL5hwNVF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4113","MSS"],"gpt_icon":0},{"id":"2608360967","title":"Oncolytics Biotech® Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2608360967","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608360967?lang=en_us&edition=fundamental","pubTime":"2026-02-04 21:50","pubTimestamp":1770213000,"startTime":"0","endTime":"0","summary":"Strong efficacy signals showing 33% ORR, 16.6-month PFS, and 27-month OS, improving on the SOC by 2-3X in a difficult-to-treat population Company to launch controlled study in second-line KRAS-mutant ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/04/3232074/0/en/Oncolytics-Biotech-Receives-FDA-Fast-Track-Designation-for-Pelareorep-in-2L-KRAS-Mutant-MSS-Metastatic-Colorectal-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4113","MSS","BK4585","BK4588","LABU"],"gpt_icon":0},{"id":"2605440405","title":"Expanding Nadunolimab’s Oncology Footprint: Low-Cost MSS-CRC Study De-Risks Pivotal Pancreatic Program and Supports Buy Rating on Cantargia AB","url":"https://stock-news.laohu8.com/highlight/detail?id=2605440405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605440405?lang=en_us&edition=fundamental","pubTime":"2026-01-24 00:56","pubTimestamp":1769187383,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Sara Nik has reiterated their bullish stance on 7V3 stock, giving a Buy rating on January 15. Sara Nik has given his Buy ra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/expanding-nadunolimabs-oncology-footprint-low-cost-mss-crc-study-de-risks-pivotal-pancreatic-program-and-supports-buy-rating-on-cantargia-ab-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/expanding-nadunolimabs-oncology-footprint-low-cost-mss-crc-study-de-risks-pivotal-pancreatic-program-and-supports-buy-rating-on-cantargia-ab-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MSS","CRC","AB"],"gpt_icon":0},{"id":"2605847027","title":"Press Release: Adagene Provides Business Update and 2026 Objectives","url":"https://stock-news.laohu8.com/highlight/detail?id=2605847027","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605847027?lang=en_us&edition=fundamental","pubTime":"2026-01-23 21:00","pubTimestamp":1769173200,"startTime":"0","endTime":"0","summary":"Data update from the ongoing Phase 1b/2 study of muzastotug + pembrolizumab in 3L+ MSS CRC patients remains on track for Q1 2026. Unaudited cash and cash equivalents of $74.5 million as of December 31, 2025 anticipated to provide sufficient runway into late 2027. SAN DIEGO and SUZHOU, China, Jan. 23, 2026  -- Adagene Inc.  , a company transforming the discovery and development of novel antibody-based therapies, today announced year-end unaudited cash and cash equivalents of $74.5 million and provided a business update.-- Phase 1b/2 trial results with muzastotug in MSS CRC at ASCO: Shared. updated data from 10 mg/kg and 20 mg/kg cohorts at ASCO 2025,demonstrating a favorable safety profile at 10-20x times higher dosing. than first generation CTLA-4 inhibitors. Encouraging overall response. rates and durable responses suggest potential for long-term survival. -- FDA Fast Track designation for muzastotug in combination with Merck's. selection, trial design, patient population and endpoint","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","ADAG","03160","BK4113","BK4139","BK4555","MSS","BK4585","LU0266512127.USD","R","BK4588","BK4099","BK4213","CRC","TM","BK4232","BK4022","LU0456854461.SGD"],"gpt_icon":0},{"id":"2601361831","title":"Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11","url":"https://stock-news.laohu8.com/highlight/detail?id=2601361831","media":"GlobeNewswire","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601361831?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:30","pubTimestamp":1767875400,"startTime":"0","endTime":"0","summary":"Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/08/3215277/0/en/Acrivon-Therapeutics-Announces-Positive-ACR-368-Phase-2b-Endometrial-Cancer-Clinical-Data-with-EU-Expansion-to-Accelerate-Enrollment-Initial-ACR-2316-Clinical-Data-and-ACR-6840-its.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAQC","LENZ","ORR","BK4139","BK4201","BK4113","BK4110","BK4007","MSS","BK4539","EDC","ACR","BK4156","EC"],"gpt_icon":0},{"id":"2595795422","title":"Maison Solutions Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2595795422","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595795422?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:09","pubTimestamp":1767089340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MSS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 30, 2025 05:09 ET (10:09 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSS"],"gpt_icon":0},{"id":"2593745857","title":"Maison Solutions Q2 EPS $(0.23) Down From $(0.01) YoY, Sales $27.625M Miss $29.500M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2593745857","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593745857?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:07","pubTimestamp":1766437630,"startTime":"0","endTime":"0","summary":"Maison Solutions (NASDAQ:MSS) reported quarterly losses of $(0.23) per share. This is a 2200 percent decrease over losses of $(0.01) per share from the same period last year.  The company reported quarterly sales of","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/12/49549409/maison-solutions-q2-eps-0-23-down-from-0-01-yoy-sales-27-625m-miss-29-500m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maison Solutions Q2 EPS $(0.23) Down From $(0.01) YoY, Sales $27.625M Miss $29.500M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSS"],"gpt_icon":0},{"id":"2592665751","title":"BRIEF-Maison Solutions Inc Enters Consent And Waiver With Investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2592665751","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592665751?lang=en_us&edition=fundamental","pubTime":"2025-12-19 19:22","pubTimestamp":1766143363,"startTime":"0","endTime":"0","summary":"BRIEF-Maison Solutions Inc Enters Consent And Waiver With InvestorDec 19  - Maison Solutions Inc MSS.O:MAISON SOLUTIONS INC - ENTERS CONSENT AND WAIVER WITH INVESTOR - SEC FILINGMAISON SOLUTIONS: UNDER AGREEMENT, SOME RESTRICTIVE COVENANTS IN NOTES & THEIR RELATED TRANSACTION DOCUMENTS WERE WAIVED FOR A LIMITED PURPOSEFurther company coverage: MSS.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XO1DT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSS","BK4113"],"gpt_icon":0},{"id":"2592657701","title":"Maison Solutions Inc - Enters Consent and Waiver With Investor - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2592657701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592657701?lang=en_us&edition=fundamental","pubTime":"2025-12-19 19:10","pubTimestamp":1766142634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XO1DT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4113","MSS"],"gpt_icon":0},{"id":"2592650941","title":"Maison Solutions: Under Agreement, Some Restrictive Covenants in Notes & Their Related Transaction Documents Were Waived for a Limited Purpose","url":"https://stock-news.laohu8.com/highlight/detail?id=2592650941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592650941?lang=en_us&edition=fundamental","pubTime":"2025-12-19 19:10","pubTimestamp":1766142634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XO1DT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MSS","BK4113"],"gpt_icon":0},{"id":"2591684751","title":"Maison Solutions Inc. Delays Financial Report Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2591684751","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591684751?lang=en_us&edition=fundamental","pubTime":"2025-12-13 06:25","pubTimestamp":1765578335,"startTime":"0","endTime":"0","summary":"Maison Solutions Inc. has disclosed a delay in filing its quarterly financial report for the period ended October 31, 2025. The company was unable to timely prepare and finalize the necessary financial information required for its Form 10-Q, but expects to file within the extension period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maison Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL5GhHKN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4113","MSS"],"gpt_icon":0},{"id":"2589870642","title":"Consumer Tech News (Dec 1-5): Trump Says He's Back in Elon Musk's Social Circle, U.S. Suspends China MSS Sanctions & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2589870642","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589870642?lang=en_us&edition=fundamental","pubTime":"2025-12-07 22:46","pubTimestamp":1765118760,"startTime":"0","endTime":"0","summary":"Trump claims he has restored ties with Elon Musk, signaling a thaw in their relationship after earlier conflicts, sparking attention in the tech and political world. Conservative advocacy groups, including Steve Bannon, urge Trump administration to stop Big Tech from using copyrighted content for AI training without permission.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/07/Donald-Trumps-Conversation-With-Elon-Mus.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/07/Donald-Trumps-Conversation-With-Elon-Mus.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/large-cap/25/12/49247787/consumer-tech-news-dec-1-5-trump-says-hes-back-in-elon-musks-social-circle-u-s-suspends-china-mss-sanctions-more","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/large-cap/25/12/49247787/consumer-tech-news-dec-1-5-trump-says-hes-back-in-elon-musks-social-circle-u-s-suspends-china-mss-sanctions-more","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["F","NVD3.UK","PSQ","QLD","TQQQ","NVD2.UK","NQmain","NVD","ACN","TSLA","NVDS.UK","UFO","AI","SQQQ","NVDD","MNQmain","SNVD.UK","USJW.SI","RIVN","TSYW.SI","MSS","USAW.SI","NVDY","2NVD.UK","3NVD.UK",".IXIC","QID","DXYZ"],"gpt_icon":1},{"id":"2588889355","title":"US Reportedly Pauses Salt-Typhoon Sanctions On China, Shelves New Export Controls To Protect Trade Truce","url":"https://stock-news.laohu8.com/highlight/detail?id=2588889355","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588889355?lang=en_us&edition=fundamental","pubTime":"2025-12-04 19:47","pubTimestamp":1764848820,"startTime":"0","endTime":"0","summary":"The United States has reportedly decided to suspend the imposition of sanctions on China's Ministry of State Security (MSS) to preserve the trade truce between the two nations.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/04/Usa-And-China-Flags-Painted-On-Cracked-W.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/04/Usa-And-China-Flags-Painted-On-Cracked-W.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/legal/25/12/49204497/us-reportedly-pauses-salt-typhoon-sanctions-on-china-shelves-new-export-controls-to-protect-trade-truce","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/legal/25/12/49204497/us-reportedly-pauses-salt-typhoon-sanctions-on-china-shelves-new-export-controls-to-protect-trade-truce","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU1430594728.SGD","LU1046421795.USD","LU1778281490.HKD","LU2286300806.USD","BK4515","IE00BFXG1179.USD","LU1674673428.USD","LU2417539215.USD","LU1032955483.USD","LU1674673691.USD","LU0731783394.SGD","LU1585245621.USD","IE00BSNM7G36.USD","BK4585","SG9999002232.USD","MSS","BK4550","LU1235294995.USD","LU2456880835.USD","LU1929549753.HKD","LU0234570918.USD","IE00BKVL7J92.USD","LU0950375773.USD","LU1823568750.SGD","SG9999015986.USD","CSCO","LU0348723411.USD","LU1066051498.USD","LU2506951875.HKD","IE00B1BXHZ80.USD","LU1221951046.USD","LU1221951129.SGD","LU0792757196.USD","LU2247934214.USD","BK4525","LU0203347892.USD","BK4581","IE00BVYPNW00.USD","LU1244550494.USD","LU2237443382.USD","LU1162221912.USD","LU1267930813.SGD","LU1880398471.USD","BK4579","IE00BZ1G4Q59.USD","LU0889566641.SGD","SG9999002224.SGD","SG9999015978.USD","LU2236285917.USD","LU1506573853.SGD"],"gpt_icon":0},{"id":"1193182286","title":"MIIT Launches Commercial Trials for Satellite IoT Services","url":"https://stock-news.laohu8.com/highlight/detail?id=1193182286","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193182286?lang=en_us&edition=fundamental","pubTime":"2025-11-28 16:11","pubTimestamp":1764317470,"startTime":"0","endTime":"0","summary":"The Ministry of Industry and Information Technology (MIIT) has issued a notice to organize commercial trials for satellite Internet of Things (IoT) services, with a trial period of two years....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4170","OSS","MSS","BK4113"],"gpt_icon":0},{"id":"2585246683","title":"China threat policy questioned amid urgent MI5 warnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2585246683","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585246683?lang=en_us&edition=fundamental","pubTime":"2025-11-24 18:57","pubTimestamp":1763981839,"startTime":"0","endTime":"0","summary":"Chinese state-linked operatives are running \"relentless\" influence/ Despite MI5 sounding its most urgent alarm over Chinese intelligence activity in Westminster yet, the UK government has refused to label China a national security threat.According to new MI5 analysis circulated to MPs last week, Chinese state-linked operatives are running “relentless” influence and information-gathering operations across Whitehall,using LinkedIn to target parliamentary researchers, advisers, and economists.Yet, even as the security services ramp up their warnings, the political system around them is pulling them in the other direction.The Crown Prosecution Service  recently collapsed a high-profile spy case after ministers refused to confirm that China meets the legal threshold of a national security threat, a move that stunned intelligence specialists and triggered political backlash.One Commons researcher told the BBC he received a job offer from one of the profiles, written in broken English.“If it ","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2022/12/GettyImages-631967732.jpg-2-1.jpeg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2022/12/GettyImages-631967732.jpg-2-1.jpeg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/china-threat-policy-questioned-amid-urgent-mi5-warnings/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/china-threat-policy-questioned-amid-urgent-mi5-warnings/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["CPS","BK4124","BK4113","MSS"],"gpt_icon":0},{"id":"2584937254","title":"MI5 warned Whitehall China uses LinkedIn to spy on MPs","url":"https://stock-news.laohu8.com/highlight/detail?id=2584937254","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584937254?lang=en_us&edition=fundamental","pubTime":"2025-11-18 20:48","pubTimestamp":1763470113,"startTime":"0","endTime":"0","summary":"Lindsay told MPs that Beijing’s objective was to “collect information and lay the groundwork for long-term relationships” using networking platforms, recruiters and consultants acting covertly.Stay ahead with our three daily briefings delivering all the key market moves, top business and political stories, and incisive analysis straight to your inbox.Security minister Dan Jarvis is expected to update the Commons later today on the government’s response to Chinese espionage activity.China spy prosecution escalatesThe warning lands in the midst of a broader row over the UK’s handling of threats from Beijing, following the collapse of a high-profile prosecution last month.The Crown Prosecution Service dropped charges against two men accused of spying for China after prosecutors were unable to secure government confirmation that Beijing constitutes a national security threat, a legal threshold required for conviction.","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2025/11/GettyImages-2204478580-1.jpg?w=286&h=161&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2025/11/GettyImages-2204478580-1.jpg?w=286&h=161&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/mi5-warned-whitehall-china-uses-linkedin-to-spy-on-mps/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/mi5-warned-whitehall-china-uses-linkedin-to-spy-on-mps/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BK4113","MSS","LNKD"],"gpt_icon":0},{"id":"2583679215","title":"Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583679215","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583679215?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:30","pubTimestamp":1763037000,"startTime":"0","endTime":"0","summary":"Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver metastases and high plasma tumor mutational burden. Presented Phase 1 data at SITC for efarindodekin alfa showing promising monotherapy anti-tumor activity and generally well-tolerated safety profile in patients with advanced solid tumors. Announced new preclinical data at SITC for masked T cell engager programs supporting best-in-class potential and showing efficient masking, potent anti-tumor activity and broad therapeutic index. Anticipate cash runway into the first quarter of 2027. WALTHAM, Mass., Nov. 13, 2025  -- Xilio Therapeutics, Inc. , a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced pipeline progress and business updates and reported financial results for the third quarter ended September 30, 2025.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","MSS","BK4007","ORR","BK4232","BK4539","LU0053666078.USD","BK4231","L","BK4022","BK4080","LU0210528500.USD","BK4139","LENZ","XLO","BK4113","BK4107","SITC","TMB","BK4588","R","LU2487616109.SGD"],"gpt_icon":0},{"id":"2581628886","title":"Press Release: Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581628886","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581628886?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:05","pubTimestamp":1762524300,"startTime":"0","endTime":"0","summary":"40% ORR in heavily pre-treated patients with MSS mCRC without liver metastases and with high plasma tumor mutational burden . Estimate 55% of patients with MSS CRC have high plasma TMB, representing a meaningful population with high unmet need. \"These compelling new Phase 2 data for vilastobart in combination with atezolizumab demonstrated a 40% objective response rate in heavily pre-pretreated patients with MSS mCRC without liver metastases and with high plasma TMB, signifying an important advance in our understanding of response to novel immunotherapy in MSS mCRC,\" said Katarina Luptakova, M.D., chief medical officer of Xilio. \"In addition, these data showed a statistically significant correlation between plasma-based TMB and response. We estimate that approximately 55% of patients with MSS CRC have high plasma TMB, representing a meaningful patient population who could ultimately benefit from combination treatment with vilastobart and a substantially greater prevalence of patients w","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B12V2V27.USD","MSS","L","BK4232","BK4107","LU2039709279.SGD","BK4113","ORR","XLO","LU1023057109.AUD","BK4585","IE00BYTNYN87.SGD","LU0456842615.SGD","IE0003851619.USD","SITC","01308","BK4535","BK4563","LENZ","BK4231","BK4552","IE0003795394.USD","LU0359202008.SGD","TMB","BK4509","BK4022","BK4108","TME","BK4548","BK4139","BK1103","LU0210528500.USD","R","BK4588","IE00BYQNZ168.SGD","BK4007","BK4531","BK1541","LU0053666078.USD","SG9999011746.SGD","LU2487616109.SGD","01698","BK4571","BK4080","BK4539","BK4526","LU0359201612.USD","BK4565"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":61,"code":"91000000","status":"200"}]}}